Professional Documents
Culture Documents
yc54p-0ewpv
yc54p-0ewpv
HIV in Myanmar
The Myanmar National Strategic Plan for HIV and AIDS, 2021-2025
(NSP IV) reflects the insights and expertise of all stakeholders, as well as the
contributions, time and energy of resource persons, organizations and
communities who will continue to work together in partnership to achieve its
goals and objectives.
HIV prevalence is about 0.57%of the population. 11,000 new infections
during the year. About 220,000 people living with HIV. 66% of people living
with HIV are currently receiving Anti Retroviral Treatment (ART).
Everyone diagnosed with HIV should take antiretroviral therapy
medicines, also called ART. This is true no matter what stage the disease is in
or what the complications are. ART is usually a mix of two or more medicines
from several classes. This approach has the best chance of lowering the amount
of HIV in the blood.
HIV prevalence in the adult population aged 15 years and older was
estimated at 0.54 per cent in 2014, a decline from 0.94 per cent in 2000. HIV in
Myanmar is concentrated among key populations: people who inject drugs (23.1
per cent), men who have sex with men (6.6 per cent) and female sex workers
(6.3 per cent).
ME EP-2
ME.EP-2